Search

Your search keyword '"Apotheek Opleiding"' showing total 98 results

Search Constraints

Start Over You searched for: Author "Apotheek Opleiding" Remove constraint Author: "Apotheek Opleiding"
98 results on '"Apotheek Opleiding"'

Search Results

1. Tacrolimus Variability and Clinical Outcomes in the Early Post-lung Transplantation Period: Oral Versus Continuous Intravenous Administration

2. IgM anti-GM2 antibodies in patients with multifocal motor neuropathy target Schwann cells and are associated with early onset

3. Cortisol as Biomarker for CYP17-Inhibition is Associated with Therapy Outcome of Abiraterone Acetate

5. Virological and immunological correlates of HIV posttreatment control after temporal antiretroviral therapy during acute HIV infection

6. Functional determination of emicizumab in presence of factor VIII activity

7. Pharmacogenetics and phenoconversion: the influence on side effects experienced by psychiatric patients

8. Continuous infusion of cefiderocol in a critically ill patient with continuous venovenous haemofiltration

9. Optimization of a Quantitative Anti-Drug Antibodies against Infliximab Assay with the Liquid Chromatography-Tandem Mass Spectrometry: A Method Validation Study and Future Perspectives

10. The efficacy of the entire-vial dosing of emicizumab: Real-world evidence on plasma concentrations, bleeds, and drug waste

12. Dosing Therapeutic Radiopharmaceuticals in Obese Patients

13. Systemic glucocorticoid use during ICU admission and symptoms of posttraumatic stress disorder in intensive care unit survivors

14. Association Between the Magnitude of Intravenous Busulfan Exposure and Development of Hepatic Veno-Occlusive Disease in Children and Young Adults Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation

15. Everolimus Concentration in Saliva to Predict Stomatitis: A Feasibility Study in Patients with Cancer

16. Clinical pharmacology of cytotoxic drugs in neonates and infants: Providing evidence-based dosing guidance

18. The effect of a decision support system on the incidence of prescription errors in a PICU

19. Emicizumab Dosing in Children and Adults with Hemophilia A: Simulating a User-Friendly and Cost-Efficient Regimen

20. Worse capecitabine treatment outcome in patients with a low skeletal muscle mass is not explained by altered pharmacokinetics

21. Association between Genetic Variants and Cisplatin-Induced Nephrotoxicity: A Genome-Wide Approach and Validation Study

22. The effect of non-adherence to antipsychotic treatment on rehospitalization in patients with psychotic disorders

23. Geneesmiddelgerelateerde ziekenhuisopnames bij ouderen: zijn ze te voorkomen met een medicatiebeoordeling in het ziekenhuis?

24. Pharmacokinetics and Associated Efficacy of Emicizumab in Humans: A Systematic Review

26. Development and validation of a combined liquid chromatography tandem-mass spectrometry assay for the quantification of aprepitant and dexamethasone in human plasma to support pharmacokinetic studies in pediatric patients

27. An International Consensus List of Potentially Clinically Significant Drug-Drug Interactions in Older People

29. Population Pharmacokinetics of Intracellular 5-Fluorouridine 5'-Triphosphate and its Relationship with Hand-and-Foot Syndrome in Patients Treated with Capecitabine

30. Randomized trial of intravenous immunoglobulin maintenance treatment regimens in chronic inflammatory demyelinating polyradiculoneuropathy

31. Population pharmacokinetics of clofarabine for allogeneic hematopoietic cell transplantation in paediatric patients

32. Cost-Effectiveness Assessment of Monitoring Abiraterone Levels in Metastatic Castration-Resistant Prostate Cancer Patients

33. Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): Cluster randomised controlled trial

34. Influence of allopurinol on thiopurine associated toxicity: A retrospective population-based cohort study

35. Chloroquine-induced QTc prolongation in COVID-19 patients

36. Acute renal and neurotoxicity due to weight-based dosing of intravenous acyclovir: How to dose in obese patients?

37. Neutrophil fluorescence in clozapine users is attributable to a 14kDa secretable protein

38. Comparison between coagulation factor VIII quantified with one-stage activity assay and with mass spectrometry in haemophilia A patients: Proof of principle

39. Pharmacogenetics of antitumor necrosis factor therapy in severe sarcoidosis

40. Cisplatin and carboplatin pharmacokinetics in a pediatric patient with hepatoblastoma receiving peritoneal dialysis

42. Adverse events related to biologicals used for patients with multiple sclerosis: a comparison between information originating from regulators and information originating from the scientific community

43. Reporting Patterns of Sialorrhea Comparing Users of Clozapine to Users of Other Antipsychotics: A Disproportionality Analysis Using VigiBase

44. Prediction of drug exposure in critically ill encephalopathic neonates treated with therapeutic hypothermia based on a pooled population pharmacokinetic analysis of seven drugs and five metabolites

45. Translation from animal to clinical studies, choosing the optimal moment

46. Evaluation of clarity of the STOPP/START criteria for clinical applicability in prescribing for older people: A quality appraisal study

47. Intervention protocol: OPtimising thERapy to prevent avoidable hospital Admission in the Multi-morbid elderly (OPERAM): A structured medication review with support of a computerised decision support system

49. Pharmacokinetics and short-term safety of the selective NOS inhibitor 2-iminobiotin in asphyxiated neonates treated with therapeutic hypothermia

50. Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO

Catalog

Books, media, physical & digital resources